- Home
- Publications
- Publication Search
- Publication Details
Title
PET/CT in Multiple Myeloma: Beyond FDG
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-25
DOI
10.3389/fonc.2020.622501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging
- (2020) Gary A. Ulaner et al. RADIOLOGY
- 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
- (2020) Xiang Zhou et al. Cancers
- Standardization of 18F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma
- (2020) Elena Zamagni et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple Myeloma
- (2019) Constantin Lapa et al. CLINICAL NUCLEAR MEDICINE
- Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
- (2019) Qingqing Pan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging in multiple myeloma: Which? When?
- (2018) Elena Zamagni et al. BLOOD
- Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study
- (2017) Philippe Moreau et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of 18 F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
- (2017) Michele Cavo et al. LANCET ONCOLOGY
- CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
- (2017) Constantin Lapa et al. Theranostics
- 11C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
- (2017) Constantin Lapa et al. Theranostics
- [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values
- (2017) Constantin Lapa et al. Theranostics
- 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study
- (2016) Thibaut Cassou-Mounat et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
- (2015) E. Zamagni et al. CLINICAL CANCER RESEARCH
- 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the Prediction of Outcome of Patients With Multiple Myeloma
- (2015) Rosa Fonti et al. CLINICAL NUCLEAR MEDICINE
- In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
- (2015) K. Philipp-Abbrederis et al. EMBO Molecular Medicine
- First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
- (2015) K. Herrmann et al. JOURNAL OF NUCLEAR MEDICINE
- Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy
- (2015) B Siontis et al. Blood Cancer Journal
- Impact of Initial FDG-PET/CT and Serum-Free Light Chain on Transformation of Conventionally Defined Solitary Plasmacytoma to Multiple Myeloma
- (2014) G. Fouquet et al. CLINICAL CANCER RESEARCH
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Clinical value of 11C-methionine PET/CT in patients with plasma cell malignancy: comparison with 18F-FDG PET/CT
- (2013) Yuji Nakamoto et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG PET or PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma
- (2012) Yu-Yu Lu et al. CLINICAL NUCLEAR MEDICINE
- 18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: A systematic review
- (2011) Danielle van Lammeren-Venema et al. CANCER
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
- (2009) T. B. Bartel et al. BLOOD
- FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma
- (2008) P.-Y. Salaun et al. HAEMATOLOGICA
- 18F-FDG PET/CT, 99mTc-MIBI, and MRI in Evaluation of Patients with Multiple Myeloma
- (2008) R. Fonti et al. JOURNAL OF NUCLEAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now